Outline of the National Action Planfor Novel Influenza, etc.

Outline of the National Action Plan for Novel Influenza, etc. (2)Outline of 13 items subject to the measures(1) Implementation system(2) Information collection and analysis (3) Surveillance(4) Providing and sharing of information and riskcommunication• Ensure systems to take effective measures through mutual
cooperation among various entities, including the national
and local governments, JIHS, research institutions, and medical
institutions, and through international coordination• Strengthen the response capacity by securing anddeveloping human resources and conducting practicaltraining in normal times, and making appropriate policy
decisions and implementing policies under the initiative of theGovernment Countermeasures Headquarters based on thebasic action policy in emergencies• Conduct comprehensive risk assessment of infectious
diseases and medical conditions, and consideration of thenational life and economy in determining measures against
infectious diseases(5) Border measures(6) Prevention of spread(7) Vaccines• Take comprehensive border measures, including strengthening ofquarantine measures and entry restrictions, to slow down the speedof entry and spread of novel influenza virus and other pathogens
into Japan• Based on the characteristics of pathogens, etc., comprehensively
consider the effectiveness and feasibility of measures and theimpact on the national life and socioeconomic activities, etc. andselect and determine border measures to be implemented• Review measures, such as reduction or suspension, as the situation
evolves• Control the speed and peak of the spread of infection to keep thenumber of patients requiring treatment within the range of the medicalcare delivery system while expanding the system• Based on the Strategy for Strengthening Vaccine Development andProduction System, promote research and development of vaccines
for priority infectious diseases in normal times and strengthen thefoundation for research and development• Reduce or discontinue measures in a flexible manner in response tochanges in the status of vaccines, therapeutic agents, etc.

(8) Medical care

(9) Therapeutics(10) Testing• Provision of medical care is essential to minimize adverse healtheffects and leads to minimal impact on social and economic activities• Promote research and development of therapeutic agents forpriority infectious diseases in normal times to strengthen thefoundation for research and development• Detect patients early and accurately understand theepidemic situation by conducting timely tests for people
requiring tests, in order to appropriately provide medical
treatment and take appropriate measures and flexibly changethem• Based on prevention plans and medical care plans, establish systems toprovide medical care for patients with infectious diseases through theconclusion of medical care agreements between prefectures andmedical institutions in normal times• In emergencies, ensure systems capable of providing medical care forpatients with infectious diseases, while keeping in mind compatibility
with conventional medical care, and respond flexibly and promptly
to situations that change according to pathogenicity and infectivity, etc.

• Implement efficient and effective surveillance andinformation collection and analysis in normal times throughthe establishment of surveillance and information collection andanalysis systems and the promotion of DX• Take necessary measures in a timely and appropriate manner in theevent of a medical crisis, including intensive measures forprevention of spread of infection, etc. and declaration of a state ofemergency, etc.

• Provide consistent measures and support for research anddevelopment, clinical trials, pharmaceutical approval,
manufacturing, distribution, administration, collection of
prognostic information and response to secure therapeutic
agents and establish therapeutic methods in emergencies• Under the infectious disease crisis, there is a risk of conflicting
information, prejudice and discrimination, and the dissemination ofdisinformation and misinformation• Communicate interactively as much as possible and share risk
information and perspectives so that people can make appropriate
judgments and actions, in order to effectively implement measuresagainst infectious diseases• Carry out public awareness activities on infectious diseases,
establish risk communication systems, and review methods forproviding and sharing information, etc. in normal times• Establish systems to secure vaccines developed in Japan and overseas
and to promote rapid vaccination in emergencies• Promote digitalization of vaccination procedures and risk
communication• Secure equipment and materials in normal times, conduct
early tests immediately after the outbreak, and flexibly change
policies for conducting tests in light of the characteristics ofpathogens and tests after the initial stage of the epidemic(11) Health(12) Supplies(13) National life and economy• Protect the lives and health of residents by taking effective measuresin response to local circumstances in emergencies• In case of shortage of infectious disease control supplies*,
there is a possibility that the conducting of quarantine,
medical treatment, and tests, etc. will be delayed• In the event of an infectious disease crisis, national life andsocioeconomic activities may be greatly affected• Implement at public health centers and public health institutes, etc.,
prefectural governments, etc. : tests, active epidemiologicalinvestigation, hospitalization recommendations and measures,
adjustment of medical treatment facilities, transfers, healthobservation, provision of foods and daily necessities, etc.
• Improve operational efficiency and eliminate labor in normal times
through the review of priority operations in emergencies and theuse of ICT and other procedures, in preparation for rapid increase inworkload• Establish systems that ensure the sufficient distribution of
infectious disease control supplies to medical facilities andother necessary institutions through stockpiling in normal times
and production requests in emergencies* Pharmaceuticals, medical devices, personal protective
equipment, etc.

• It is important to make necessary preparations for business
continuity, etc. in normal times and to stabilize the situation inemergencies• Provide necessary measures and support* to mitigate the impact by
the national government, etc.
* Request for a stable supply of daily necessities, measures to prevent the spread ofthe disease, etc. taking into account the impact on the mind and body, support forpersons in need of livelihood support, etc.

2